Literature DB >> 8946678

Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion.

J M Teng1, P D King, A Sadra, X Liu, A Han, A Selvakumar, A August, B Dupont.   

Abstract

Signaling by the CD28 T cell costimulatory receptor is known to involve recruitment and activation of phosphatidylinositol 3-kinase (PI3-kinase) which is dependent upon phosphorylation of tyrosine 173 of the CD28 cytoplasmic tail, present in a YMNM motif. However, whether this phosphorylation is required for CD28 costimulation and whether or not phosphorylation of any of the other three tyrosines of the CD28 cytoplasmic tail (tyrosines 188, 191 and 200) is also important for CD28 induced responses is unclear. To address this we examined the ability of chimeric receptors, consisting of the extracellular plus transmembrane membrane domain of human CD8 alpha linked to different mutated human CD28 cytoplasmic tails, to induce IL-2 secretion in Jurkat T leukemia cells in the presence of PMA and ionomycin. A receptor in which tyrosine 173 of the CD28 tail was mutated to phenylalanine was able to induce IL-2. By contrast, receptors which contained single tyrosine 188, 191 or 200 to phenylalanine substitutions were unable to induce IL-2. These results imply that in this system phosphorylation of tyrosine 173 and hence activation of PI3-kinase is not required for CD28 induced IL-2 secretion. Further, they imply that phosphorylation of each of tyrosines 188, 191 and 200 is necessary for this response. Despite an apparent requirement for phosphorylation of all three of these tyrosines, however, receptors which contain tyrosine only at positions 191 or 200 and a truncated receptor which does not contain tyrosine 200 induce normal IL-2. These last findings, therefore, illustrate the complexity of CD28 mediated activation signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946678     DOI: 10.1111/j.1399-0039.1996.tb02643.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28.

Authors:  Ynes A Helou; Anna P Petrashen; Arthur R Salomon
Journal:  J Proteome Res       Date:  2015-06-16       Impact factor: 4.466

2.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

3.  Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

Authors:  S Gibson; K Truitt; Y Lu; R Lapushin; H Khan; J B Imboden; G B Mills
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

5.  People's instinctive travels and the paths to science.

Authors:  Avery August
Journal:  Mol Biol Cell       Date:  2014-11-01       Impact factor: 4.138

6.  Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics.

Authors:  Jennifer A Rohrs; Dongqing Zheng; Nicholas A Graham; Pin Wang; Stacey D Finley
Journal:  Biophys J       Date:  2018-08-22       Impact factor: 4.033

7.  Phosphatidylserine binding directly regulates TIM-3 function.

Authors:  Courtney M Smith; Alice Li; Nithya Krishnamurthy; Mark A Lemmon
Journal:  Biochem J       Date:  2021-09-17       Impact factor: 3.857

8.  Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.

Authors:  A Krause; H F Guo; J B Latouche; C Tan; N K Cheung; M Sadelain
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

9.  Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production.

Authors:  Max S Topp; Stanley R Riddell; Yoshiki Akatsuka; Michael C Jensen; Joseph N Blattman; Philip D Greenberg
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.